**Question:** Which of the following is true regarding Wilm's tumor?

A. It is a rare condition affecting adults only.
B. It is caused by a genetic mutation involving the VHL gene.
C. It is a viral infection.
D. It has a uniform presentation and course across patients.

**Core Concept:** Wilm's tumor is a type of kidney cancer that primarily affects children. It is a rare condition, but can also occur in adults. The tumor is characterized by the uncontrolled growth of nephron-primordium cells, which are the precursor cells for the formation of the kidney's functional units, nephrons.

**Why the Correct Answer is Right:** Wilm's tumor is primarily caused by a genetic mutation involving the VHL (Von Hippel-Lindau) gene. The VHL gene plays a critical role in regulating the cell cycle and preventing tumor formation. In individuals with a mutated VHL gene, the risk of developing Wilm's tumor increases significantly.

**Why Each Wrong Option is Incorrect:**

A. The statement that Wilm's tumor affects adults only is incorrect. While it is relatively rare in adults, it can still occur in this population. The primary risk factor is the presence of a genetic mutation, which is more common in children and young adults.

B. The correct answer (option B) explains the genetic basis of Wilm's tumor, while option C is incorrect because it implies Wilm's tumor is a viral infection, which is not the case.

C. This option is incorrect because Wilm's tumor is not a viral infection. It is caused by genetic factors, specifically mutations in genes such as WT1 (Wilms tumor 1) and CTNNB1 (catenin beta 1), rather than being a result of a viral infection.

D. Wilm's tumor has a uniform presentation and course across patients, but the tumor can exhibit different histological (cellular) subtypes, leading to variations in treatment response and prognosis. This option is incorrect due to the diverse histological subtypes that can be found in Wilm's tumor cases.

**Clinical Pearl:** Wilm's tumor is an example of a genetic disease with predisposition to cancer due to mutations in crucial genes like WT1 and CTNNB1. It is important for physicians to be aware of genetic predisposition to Wilm's tumor in order to initiate screening and surveillance protocols in high-risk patients, as early detection can lead to better treatment outcomes and improved survival rates.